The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial - Concepedia

Concepedia

Publication | Open Access

The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

DOI Full Paper Access

74

Citations

22

References

2011

Year

Arnar Rafnsson, Felix Böhm, Magnus Settergren, Adrian Gonon, Kerstin Brismar, John Pernow

MedicineRandomised TrialDiabetesPhysiologyType 2Vascular BiologyDiabetes MellitusMicrovascular DysfunctionPharmacologyAtherosclerosis

References

	Year	Citations

Page 1